Cancer cells Archives

Oncotarget News

miR-10b Inhibition: A Strategy for Treating Metastatic Breast Cancer

August 28, 2024

We have developed a nanodrug, termed MN-anti-miR10b, that delivers anti-miR-10b antisense oligomers to cancer cells.”BUFFALO, NY- August 28, 2024 – A new research paper was published in Oncotarget's Volume 15... read more

Oncotarget

Disrupting NKG2A:HLA-E Interactions for Enhanced Anti-Cancer Immunity

August 21, 2024

there is strong preclinical evidence that disruption of NKG2A interactions with HLA-E can stimulate both NK cell and cytotoxic T cell effector functions against cancer.”BUFFALO, NY- August 21, 2024 –... read more

Oncotarget

Nanobody Inhibits Metastasis of Breast Tumor Cells to Lung in Mice

August 15, 2024

In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.”BUFFALO, NY- August 15, 2024 – A... read more

Oncotarget

Behind the Study: Osteopontin Induces Mitochondrial Biogenesis in Deadherent Cancer Cells

December 14, 2023

Dr. Georg F. Weber, from the University of Cincinnati Academic Health Center, James L. Winkle College of Pharmacy, details a research paper he co-authored that was published by Oncotarget in... read more

Figure 6: Synergistic/antagonistic combinations.

Oncotarget

Oncotarget | Selective Protection of Normal Cells From Chemotherapy, While Killing Drug-Resistant Cancer Cells

March 13, 2023

Selective protection of normal cells may transform therapy of cancer.” BUFFALO, NY- March 13, 2023 – A new review paper was published in Oncotarget's Volume 14 on March 11, 2023,... read more

Oncotarget

Behind the Study: Inhibition of Resistant Triple-negative Breast Cancer Cells

September 19, 2022

Dr. Balraj Singh from the University of Texas MD Anderson Cancer Center, describes a recent research paper he co-authored that was published by Oncotarget, entitled, “Inhibition of resistant triple-negative breast... read more

Dr. Kenneth Pienta and Dr. J. James Frost

Oncotarget

Behind the Study: Symmetry and Symmetry Breaking in Cancer

May 3, 2021

Behind the Study is a series of transcribed videos from researchers elaborating on their recent oncology-focused studies published in Oncotarget. A new Behind the Study is released each... read more

Prof. Malka Cohen-Armon and her team at Tel Aviv University's Sackler Faculty of Medicine

Oncotarget

Behind the Study: Phenanthrene and Human Pancreatic Cancer Cells

March 15, 2021

The Behind the Study series transcribes videos of researchers elaborating on their recent papers published in Oncotarget. Visit the Oncotarget YouTube channel for more... read more